MedPath

Randomized controlled trial of San-Ren Run-Chang prescription on the intervention of constipation-type irritable bowel syndrome

Not Applicable
Recruiting
Conditions
Irritable bowel syndrome-constipation
Registration Number
ITMCTR2100004525
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Comply with IBS C Roman IV diagnostic standard;
2) Aged between 18 and 70 years, gender is not limited;
3) Have not taken any medication related to the disease within at least one week before entering the study, and have not participated in any other ongoing study;
4) Colonoscopy was performed within 1 year (colon polyps, inflammatory bowel disease and other organic lesions were excluded);
5) Voluntary subject and informed consent signed by the participant;
6) Frequent residence in the location of treatment is conducive to treatment and follow-up.

Exclusion Criteria

1) Alternate diarrhea and constipation with IBS;
2) Patients with previous heart, liver and kidney tumors and organic lesions or patients with mental illness;
3) Patients with previous gastrointestinal tumors and organic lesions, such as pancreatitis, intestinal polyps (not including polypectomy for more than half a month), intestinal diverticulum, history of colon or rectal cancer, inflammatory bowel history, intestinal tuberculosis, etc.;
4) Previous metabolic diseases affecting digestive tract motility, such as thyroid disease and diabetes mellitus;
5) People with previous gastrocardiac syndrome and lactase deficiency;
6) Allergic constitution or allergic to the components of the drug under study;
7) Pregnant or lactating women, and female patients with recent family planning;
8) Previous abdominal or pelvic surgery, such as cholecystectomy;
9) People who are taking other Chinese medicine for treatment;
10) According to the researchers' judgment, patients with conditions that reduce the possibility of enrolment or complicate enrolment, such as frequent changes in work environment, are prone to loss of follow-up.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.